Acute graft-versus-host disease (aGvHD) is a common complication associated with allogenic hematopoietic stem cell transplantation (HSCT) with high morbidity and potentially fatal outcomes. The skin, gastrointestinal tract, and liver are common targets of the disease. In this activity, Sung Won Choi, MD, MS, Gianni B. Scappaticci, PharmD, BCOP, and Chelsea C. Honstain, MS, FNP-C discuss the role of the interprofessional care team in the prophylaxis and management of aGvHD according to current guidelines and available agents. The panel will also discuss emerging novel therapies for aGvHD prevention and treatment and hear from an experienced patient.
Upon completion of this activity, participants should be better able to:
Professor, MM Pediatrics – Hematology Oncology
University of Michigan
Ann Arbor, MI
Nurse Practitioner
C.S. Mott Children’s Hospital
University of Michigan
Ann Arbor, MI
Clinical Pharmacist Specialist, Adult/Pediatric BMT and Cellular Therapies
University of Michigan
Ann Arbor, MI
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
